Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.6360
+0.0136 (2.19%)
Nov 6, 2026, 4:00 PM EST - Market closed

Standard BioTools Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
133.08-74.9-138.89-74.66-190.1-59.24
Depreciation & Amortization
9.1710.9816.8615.1815.033.65
Other Amortization
-----12.54
Loss (Gain) From Sale of Assets
-202.28-----
Asset Writedown & Restructuring Costs
----3.53-
Loss (Gain) From Sale of Investments
-1.33-2.04-7.44-1.26-0.67-
Stock-Based Compensation
22.3429.6131.7313.1214.8816.1
Other Operating Activities
13.426.98-16.536.386.562.81
Change in Accounts Receivable
8.77-1.368.97-2.991.066.73
Change in Inventory
1.68-11.52-9.88-4.91-8.47-4.78
Change in Accounts Payable
-4.872.44-12.981.62-2.781.28
Change in Unearned Revenue
-30.84-1.31-4.140.88-3.47-3.21
Change in Other Net Operating Assets
-9.294.88-11.163.33-4.95-19.95
Operating Cash Flow
-64.26-74.34-143.45-43.29-89.37-44.06
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.39-8.3-8.36-2.83-3.83-13.26
Cash Acquisitions
--278.65---
Investment in Securities
-202.0240.7192.8823.07-84.3-
Other Investing Activities
-5-5---1.32
Investing Cash Flow
202.2927.41363.1720.24-88.13-11.95

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----6.84
Long-Term Debt Issued
----2510
Total Debt Issued
----2516.84
Long-Term Debt Repaid
---63.19-2.08-6.84-0.5
Net Debt Issued (Repaid)
---63.19-2.0818.1616.34
Issuance of Common Stock
0.941.052.070.830.921.49
Repurchase of Common Stock
-1.1-0.48-40.95-5.55-0.77-1.79
Other Financing Activities
---0.55--12.55-0.08
Financing Cash Flow
-0.160.57-102.62-6.81230.7615.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.320.84-0.790.03-0.4-0.02
Net Cash Flow
137.56-45.52116.32-29.8352.86-40.07

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-65.65-82.65-151.81-46.12-93.2-57.33
Free Cash Flow Growth
------
Free Cash Flow Margin
-77.76%-96.85%-166.81%-43.37%-95.15%-43.90%
Free Cash Flow Per Share
-0.17-0.22-0.43-0.58-1.19-0.76
Levered Free Cash Flow
166.87-171.83-54.61-9.27-39.97-31.59
Unlevered Free Cash Flow
166.88-171.82-52.54-6.42-37.26-29.82

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-0.023.093.823.493.15
Cash Income Tax Paid
--0.070.610.80.312.09
Change in Working Capital
-34.66-44.98-29.2-1.97-18.6-19.93
SEC Filings: 10-K · 10-Q